Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Top-down Infliximab Study in Kids With Crohn's Disease
NCT02517684Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Apr 2015
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 4 trial of infliximab in Crohn's disease, sponsored by Erasmus MC. Started Apr 2015; status: completed.
02
Drugs
infliximab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02517684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02517684.